Recent QNRX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/16/2026 12:16:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:13:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 05:34:17 PM
- Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 12:30:00 PM
- Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026 • GlobeNewswire Inc. • 04/30/2026 12:30:00 PM
- CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs • GlobeNewswire Inc. • 04/28/2026 04:02:48 PM
- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs • GlobeNewswire Inc. • 04/28/2026 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:38:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 01:35:33 PM
- Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Quoin advances QRX003 development after positive FDA meeting on Netherton syndrome • IH Market News • 03/25/2026 03:07:12 PM
- Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026 • GlobeNewswire Inc. • 03/19/2026 12:30:00 PM
- Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome • GlobeNewswire Inc. • 03/11/2026 12:30:00 PM
- NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 01:14:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:24:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:20:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:18:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:17:29 PM
